Skip to content

Comparing the Effects of Sub-Occipital Myofascial Release With and Without SNAG on People With Cervicogenic Dizziness.

Comparative Effects of Sub-Occipital Myofascial Release With and Without Sustained Natural Apophyseal Glide Among Patients With Cervicogenic Dizziness.

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07062809
Enrollment
42
Registered
2025-07-14
Start date
2025-07-24
Completion date
2025-10-20
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache, Dizziness

Keywords

Cervicogenic Dizziness, Pain, Suboccipital Myofascial Release

Brief summary

Cervicogenic dizziness is defined as a sensation of rotation, resulting from an alteration of the neck proprioceptive afferents of the upper cervical spine.Sub-occipital Release, a type of Myofascial Release (MFR) is a form of manual therapy technique which can be used for the treatment of cervicogenic dizziness. Sub-occipital muscles, dura matter and C2 vertebrae are connected to each other through the fascia. Sustained natural apophyseal glides (SNAGs) are also an effective treatment for cervicogenic dizziness. This study aim to determine Comparative Effect of Sub-Occipital Myofascial release with and without Sustained Natural Apophyseal Glide among patients with Cervicogenic Dizziness.

Detailed description

This study will be a randomized controlled trial and will be conducted in Hameed Latif Teaching Hospital and National hospital & Medical Center. Non-probability consecutive sampling will be used to collect the data. Subjects with age group between 22 to 54 years old will be taken. Data will be collected from the patients having present complaint of cervicogenic dizziness. Group A and Group B were the two randomly selected groups into which the participants were divided. Baseline assessment of pain, dizziness and Headache was taken using Visual Analogue Scale (VAS), Dizziness Handicap Inventory (DHI) and Numeric Pain Rate Scale (NPRS) respectively, before the start of treatment by an assessor. Subjects will be selected on the basis of inclusion and exclusion criteria. Both the Groups will receive Hot Pack ,TENS , Ultrasound ,and also will receive Sternocleidomastoid, Trapezius, Scalene, and Pectoralis minor muscle stretching exercises, while Group A will receive Sub-Occipital Myofascial Release and Sustained Natural Apophyseal Glide (SNAG), and Group B will receive Sub Occipital Myofascial Release. Short term effects would be assessed after treatment for 3 sessions per week on alternate days for 4 weeks. Data analysis will be done by SPSS version 25.

Interventions

OTHERSub Occipital Myofascial release and (SNAGS).

The patient will instruct to be seated then will turned his head toward direction that will cause his dizziness. when subject will turn his head, The manual therapist will perform a constant PA glide (using his thumbs one over the other) to upper cervical C1 or C2 vertebra (Oriented toward patient's eyeballs). If flexion or extension movement will provoke the dizziness, an anterior glide will apply to the C2 spinous process. If rotation will provoke dizziness, then an anterior glide will be applied to the C1 transverse process.

OTHERSub Occipital Myofascial release.

When using the technique, the patient will be in Upward-facing position with their head fully aided on the therapist's hands. The therapist will put three middle fingers simply inferior to the nuchal line, raise the tips of the fingers in the direction of the ceiling, and then simply pull them upward.

Sponsors

Riphah International University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
22 Years to 54 Years
Healthy volunteers
No

Inclusion criteria

* Cervicogenic dizziness patients both male and female. * Age group between 22 to 54 Years old. * Passive Accessory Assessment of the UCS (C0-1, C1-2, C2-3). * Dizziness related to either movements or positions of the cervical spine, or occurring with a stiff or painful neck. * Symptoms \> 3 months. * Moderate disability score on the Dizziness Handicap Inventory (DHI) \[31-60 points\] .

Exclusion criteria

* Conditions for which manual therapy is contraindicated * Traumatic brain injury * Previous surgery to the upper cervical spine and marked cervical spine disc protrusion * By neurologist .Vestibular disorders (e.g. Benign Paroxysmal Positional Vertigo, Meniere's disease, peripheral vestibulopathy) * CNS disorder (e.g.cerebellar ataxia, stroke, demyelination) * Migraine associated vertigo * Psychogenic dizziness * Cardiovascular disorders

Design outcomes

Primary

MeasureTime frameDescription
Visual Analogue Scale (VAS)4 weeksThe dizziness intensity was registered with a VAS, a valid and reliable tool for measuring dizziness intensity (reliability test-retest of this VAS is r = 0.85-0.96) .A continuous vertical line of 100 mm was anchored by two verbal descriptors (no dizziness and worst imaginable dizziness), and each end of the line had a mark; the subjects had to mark on the line the worst perceived dizziness since the last appointment (wVAS). Although it is a subjective and individual scale of the patient, it allows us to register the intensity of dizziness quickly, and its use in the clinic is widespread.

Secondary

MeasureTime frameDescription
Dizziness Handicap Inventory (DHI)4 weeksThe impact of dizziness on quality of life is often assessed by the Dizziness Handicap Inventory (DHI). The DHI contains 25 items, and a total score (0-100 points) is obtained by summing ordinal scale responses, higher scores indicating more severe handicap. The scale was developed to capture various sub-domains of self-perceived handicap and comprises 7 physical, 9 functional, and 9 emotional questions

Other

MeasureTime frameDescription
Numerical Pain Rating Scale (NPRS)4 weeksThis scale will be used to measure the patient's level of pain. The numbers on this scale go from 0 to 10. No pain is denoted by a score of 0, and worst pain by a score of 10. High test-retest reliability has been demonstrated using NPRS (r = 0.96 and 0.95, respectively)

Countries

Pakistan

Contacts

Primary ContactNaseer Ahmad Naseer Mehravi, MS student
na992311@gmail.com03037272342
Backup ContactMuzna Munir, PHD scholar
muznafmh@gmail.com03344265125

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026